The USA follows a multi-faceted approach to the pharmacovigilance services in USA . It is divided into two post-marketing systems namely, the FDA Adverse Event Report System (FAERS) for pharmaceuticals and biologic products

Risk management in pharmacovigilance is undertaken to promote safe use of medicines and safeguard health of patients.